Cargando…
Regulation of Inflammation-Related Genes through Fosl1 Suppression in a Levetiracetam-Treated Pilocarpine-Induced Status Epilepticus Mouse Model
Levetiracetam (LEV) suppresses the upregulation of proinflammatory molecules that occurs during epileptogenesis after status epilepticus (SE). Based on previous studies, LEV likely helps prevent the onset of epilepsy after insults to the brain, unlike other conventional anti-epileptic drugs. Recentl...
Autores principales: | Komori, Rie, Matsuo, Taira, Yokota-Nakatsuma, Aya, Hashimoto, Ritsuka, Kubo, Shizuka, Kozawa, Chihiro, Kono, Tomomi, Ishihara, Yasuhiro, Itoh, Kouichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317701/ https://www.ncbi.nlm.nih.gov/pubmed/35886955 http://dx.doi.org/10.3390/ijms23147608 |
Ejemplares similares
-
Levetiracetam Suppresses the Infiltration of Neutrophils and Monocytes and Downregulates Many Inflammatory Cytokines during Epileptogenesis in Pilocarpine-Induced Status Epilepticus Mice
por: Matsuo, Taira, et al.
Publicado: (2022) -
FosL1 Is a Novel Target of Levetiracetam for Suppressing the Microglial Inflammatory Reaction
por: Niidome, Kouji, et al.
Publicado: (2021) -
Additional Antiepileptic Mechanisms of Levetiracetam in Lithium-Pilocarpine Treated Rats
por: Al-Shorbagy, Muhammad Y., et al.
Publicado: (2013) -
The evolution of the pilocarpine animal model of status epilepticus
por: Ahmed Juvale, Iman Imtiyaz, et al.
Publicado: (2020) -
Mechanisms of Levetiracetam in the Control of Status Epilepticus and Epilepsy
por: Deshpande, Laxmikant S., et al.
Publicado: (2014)